FLOT vs. FLOT/Ramucirumab for Perioperative Therapy of Gastric or GEJ Cancer (RAMSES)

NCT02661971 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

180

Enrollment

OTHER

Sponsor class

Conditions

Stomach Cancer
Gastroesophageal Junction Cancer

Interventions

DRUG: Docetaxel
DRUG: Oxaliplatin
DRUG: Calciumfolinat
DRUG: 5-Fluorouracil
BIOLOGICAL: Ramucirumab

Sponsor

Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest